AI assistant
RSA INSURANCE GROUP LIMITED — Director's Dealing 2021
May 26, 2021
4719_dirs_2021-05-26_761c7ee7-2b0e-4fd1-95f4-00107d8be931.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 9357Z
RSA Insurance Group PLC
26 May 2021
RSA Insurance Group plc
("the Company")
Transactions in shares by Persons Discharging Managerial Responsibility ("PDMRs")
Ordinary Shares of £1.00 each
26 May 2021
The Company announces the following changes to the interests of PDMRs in the Company's Ordinary Shares of £1.00 each ("Shares").
On 25 May 2021 the nil cost Conditional Awards over Shares granted under the terms of the RSA Performance Share Plan 2014 ("PSP") to the following PDMRs vested as shown in the table below.
| Name | No. of Performance Shares vested | No. of Dividend Equivalent Shares on Performance Shares | No. of Bonus Deferral Shares Vested |
No. of Dividend Equivalent Shares on Bonus Deferral Shares | No. of Restricted Shares Vested |
| Stephen Hester | 1,030,213 | 37,617 | 322,071 | 4,261 | - |
| Scott Egan | 485,359 | 17,720 | 149,752 | 2,256 | - |
| Martin Thompson | 316,094 | 11,394 | 107,039 | 1,019 | - |
| Ralph Daals | 159,827 | 5,826 | 32,057 | 412 | - |
| Charlotte Heiss | 136,749 | 4,913 | 29,092 | 335 | - |
| William McDonnell | 168,716 | 6,238 | 42,851 | 511 | - |
| Karen Caddick1 | 162,272 | 3,137 | 57,491 | 501 | - |
| Charlotte Jones1,, | 408,107 | 7,865 | 87,130 | 318 | 14,277 |
| Nathan Williams | 221,762 | 8,024 | 76,640 | 888 | - |
| Kenneth Norgrove | 108,466 | 4,206 | 59,391 | 939 | - |
· Bonus Deferral Shares relate to awards made as part of the Annual Bonus Plan.
· The Dividend Equivalent Shares are added to the awards at vesting in accordance with the rules of the PSP and Directors' Remuneration Policy.
Notes to table:
1 Awards made to compensate for awards forfeited on leaving previous employer, in accordance with the Directors' Remuneration Policy, are included among those vesting.
The forms required under the EU Market Abuse Regulation follow.
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Stephen Hester
b)
Position / status
Group Chief Executive
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 1,030,213 |
d)
Aggregated information
- Aggregated volume
- Price
1,030,213
Nil
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 37,617 |
d)
Aggregated information
- Aggregated volume
- Price
37,617
Nil
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share awards granted on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 322,071 |
d)
Aggregated information
- Aggregated volume
- Price
322,071
Nil
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 4,261 |
d)
Aggregated information
- Aggregated volume
- Price
4,261
Nil
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Scott Egan
b)
Position / status
CEO, UK and International
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 485,359 |
d)
Aggregated information
- Aggregated volume
- Price
485,359
Nil
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 17,720 |
d)
Aggregated information
- Aggregated volume
- Price
17,720
Nil
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share awards granted on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 149,752 |
d)
Aggregated information
- Aggregated volume
- Price
149,752
Nil
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 2,256 |
d)
Aggregated information
- Aggregated volume
- Price
2,256
Nil
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Martin Thompson
b)
Position / status
CEO, Canada
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 316,094 |
d)
Aggregated information
- Aggregated volume
- Price
316,094
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 March 2018 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 11,394 |
d)
Aggregated information
- Aggregated volume
- Price
11,394
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share awards granted on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 107,039 |
d)
Aggregated information
- Aggregated volume
- Price
107,039
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share awards on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 1,019 |
d)
Aggregated information
- Aggregated volume
- Price
1,019
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Ralph Daals
b)
Position / status
Group Chief Auditor
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 159,827 |
d)
Aggregated information
- Aggregated volume
- Price
159,827
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 5,826 |
d)
Aggregated information
- Aggregated volume
- Price
5,826
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share awards granted on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 32,057 |
d)
Aggregated information
- Aggregated volume
- Price
32,057
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 412 |
d)
Aggregated information
- Aggregated volume
- Price
412
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Charlotte Heiss
b)
Position / status
Group General Counsel and Company Secretary
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 136,749 |
d)
Aggregated information
- Aggregated volume
- Price
136,749
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 4,913 |
d)
Aggregated information
- Aggregated volume
- Price
4,913
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share awards granted on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 29,092 |
d)
Aggregated information
- Aggregated volume
- Price
29,092
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 335 |
d)
Aggregated information
- Aggregated volume
- Price
335
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
William McDonnell
b)
Position / status
Group Chief Risk Officer
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 168,716 |
d)
Aggregated information
- Aggregated volume
- Price
168,716
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 6,238 |
d)
Aggregated information
- Aggregated volume
- Price
6,238
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share awards granted on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 42,851 |
d)
Aggregated information
- Aggregated volume
- Price
42,851
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 511 |
d)
Aggregated information
- Aggregated volume
- Price
511
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
| XLON London Stock Exchange |
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Karen Caddick
b)
Position / status
Group & UK HR Director
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share awards granted on 2 September 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 162,272 |
d)
Aggregated information
- Aggregated volume
- Price
162,272
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 September 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 3,137 |
d)
Aggregated information
- Aggregated volume
- Price
3,137
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share awards granted on 2 September 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 57,491 |
d)
Aggregated information
- Aggregated volume
- Price
57,491
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on 2 September 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 501 |
d)
Aggregated information
- Aggregated volume
- Price
501
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Charlotte Jones
b)
Position / status
Group Chief Financial Officer
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share awards granted on 2 September 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 408,107 |
d)
Aggregated information
- Aggregated volume
- Price
408,107
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 September 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 7,865 |
d)
Aggregated information
- Aggregated volume
- Price
7,865
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share awards granted on 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 87,130 |
d)
Aggregated information
- Aggregated volume
- Price
87,130
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 318 |
d)
Aggregated information
- Aggregated volume
- Price
318
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Restricted Share awards granted on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 14,277 |
d)
Aggregated information
- Aggregated volume
- Price
14,277
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Nathan Williams
b)
Position / status
Group Underwriting Director
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 221,762 |
d)
Aggregated information
- Aggregated volume
- Price
221,762
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 8,024 |
d)
Aggregated information
- Aggregated volume
- Price
8,024
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share awards granted on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 76,640 |
d)
Aggregated information
- Aggregated volume
- Price
76,640
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 888 |
d)
Aggregated information
- Aggregated volume
- Price
888
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Kenneth Norgrove
b)
Position / status
CEO RSA Scandinavia
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 16 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 108,466 |
d)
Aggregated information
- Aggregated volume
- Price
108,466
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Performance Share awards on 2 March 2018 & 8 March 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 4,206 |
d)
Aggregated information
- Aggregated volume
- Price
4,206
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share awards granted on 8 March 2019, 16 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 59,391 |
d)
Aggregated information
- Aggregated volume
- Price
59,391
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on 8 March 2019 &16 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 939 |
d)
Aggregated information
- Aggregated volume
- Price
939
NIL
e)
Date of the transaction
25 May 2021
f)
Place of the transaction
XLON London Stock Exchange
Enquiries to:
Christopher Smyth, Deputy Group Company Secretary
RSA Insurance Group plc
Tel: +44 (0) 20 7111 7000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHZQLFLFELLBBD